Incyte (INCY) EPS (Basic) (2010 - 2026)

Incyte's (INCY) quarterly EPS (Basic) came in at $2.92 in Q2 2026, up 39.99% YoY from $2.09 in Q2 2025, and up 92.06% on a QoQ basis from $1.52 in Q1 2026.

Incyte (INCY) EPS (Basic) (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of EPS (Basic) data on file, last reported at $2.92 in Q2 2026.

  • Quarterly EPS (Basic) rose 39.99% year-over-year to $2.92 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.05 (up 79.25% YoY) and the FY2025 annual result came in at $6.59, up 4085.58% from the prior year.
  • EPS (Basic) advanced to $2.92 in Q2 2026, from $1.52 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $2.92 in Q2 2026 to a low of -$2.04 in Q2 2024.
  • A 5-year average of $0.86 and a median of $0.79 in 2023 frame the typical range for EPS (Basic).
  • The widest YoY moves for EPS (Basic): up 675.92% in 2024, down 323.5% in 2024.
  • Tracing INCY's EPS (Basic) over 5 years: stood at $0.13 in 2022, then jumped by 601.38% to $0.9 in 2023, then advanced by 8.05% to $0.97 in 2024, then soared by 57.81% to $1.53 in 2025, then jumped by 90.62% to $2.92 in 2026.
  • The last three EPS (Basic) figures came in at $2.92 (Q2 2026), $1.52 (Q1 2026), and $1.53 (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Incyte 24.15 Bn 19.61 Bn 1.57 Bn 2.92

Historic Data

Download Data
DateValue
Jun 30, 2026 2.92
Mar 31, 2026 1.52
Dec 31, 2025 1.53
Sep 30, 2025 2.17
Jun 30, 2025 2.09
Mar 31, 2025 0.82
Dec 31, 2024 0.97
Sep 30, 2024 0.55
Jun 30, 2024 -2.04
Mar 31, 2024 0.76
Dec 31, 2023 0.90
Sep 30, 2023 0.76
Jun 30, 2023 0.91
Mar 31, 2023 0.10
Dec 31, 2022 0.13
Sep 30, 2022 0.51
Jun 30, 2022 0.73
Mar 31, 2022 0.17
Dec 31, 2021 2.56
Sep 30, 2021 0.82